Urology · Royal Oak, MI
NPI
1326067067
Since 2006
Specialty
Urology
Code 2088F0040X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
3535 W 13 Mile Rd Ste 404
Royal Oak, MI, 48073
Phone (248) 551-3535
Groups this clinician bills Medicare through
Medicare paid, 2024
$310K
7,280 services
Medicare patients, 2024
1,323
Average age 76
Drug cost, 2024
$877K
4,186 prescriptions
Company payments, 2025
$2,705
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Melissa C Fischer was code 81003 (clinical chemistry), 1,081 times for 765 patients. In total Melissa C Fischer billed 7,280 services in 118 codes, and Medicare paid $310K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 81003 Clinical Chemistry | Office | 1,081 | 765 | $2.18 | $2,361 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 904 | 699 | $12.54 | $11K |
| 99213 Office E&M - Established | Office | 525 | 458 | $67.56 | $35K |
| 99214 Office E&M - Established | Office | 438 | 378 | $99.08 | $43K |
| 51798 Ultrasound - Nonspecific | Office | 266 | 234 | $8.42 | $2,240 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 238 | 131 | $37.83 | $9,003 |
| 99204 Office E&M - New | Office | 187 | 187 | $123.32 | $23K |
| 99232 Hospital E&M - Subsequent | Facility | 175 | 127 | $64.70 | $11K |
| 99459 Office/Outpatient Services | Office | 140 | 137 | $16.75 | $2,345 |
| 52000 Cystourethroscopy | Office | 135 | 121 | $180.19 | $24K |
| 99222 Hospital E&M - Initial | Facility | 125 | 119 | $107.68 | $13K |
| 99212 Office E&M - Established | Office | 114 | 108 | $38.15 | $4,349 |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 78 | 20 | $51.45 | $4,013 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 60 | 21 | $50.78 | $3,047 |
| 99223 Hospital E&M - Initial | Facility | 49 | 47 | $143.29 | $7,021 |
By year: 2022 $322K for 7,378 services; 2023 $277K for 4,819 services; 2024 $310K for 7,280 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 1,081 | 765 | $2.18 | $2,361 |
| 80048 Clinical Chemistry | 32 | 32 | $8.29 | $265 |
| 84153 Clinical Chemistry | 22 | 20 | $18.02 | $396 |
Medicare prescription drug claims, 2024
In 2024, the drug Melissa C Fischer prescribed most often to Medicare patients was Myrbetriq (Mirabegron), with 582 prescriptions and refills. In total Melissa C Fischer wrote 4,186 Medicare prescriptions that cost $877K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Myrbetriq Mirabegron | 582 | 1,306 | 203 | $563K |
| Solifenacin Succinate Generic | 490 | 1,234 | 186 | $22K |
| Methenamine Hippurate Generic | 459 | 1,104 | 156 | $36K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 437 | 439 | 256 | $4,191 |
| Trospium Chloride Generic | 251 | 673 | 103 | $18K |
| Mirabegron Er Mirabegron | 207 | 439 | 91 | $118K |
| Cefadroxil Generic | 187 | 187 | 115 | $1,224 |
| Tolterodine Tartrate Er Tolterodine Tartrate | 184 | 415 | 51 | $19K |
| Tamsulosin Hcl Generic | 183 | 475 | 71 | $3,357 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 131 | 135 | 87 | $314 |
| Finasteride Generic | 127 | 318 | 37 | $2,159 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 121 | 342 | 40 | $4,344 |
| Estradiol Generic | 116 | 320 | 78 | $6,974 |
| Cephalexin Generic | 93 | 186 | 55 | $1,971 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 91 | 91 | 62 | $617 |
Brand drugs: - claims; generic drugs: 3,397 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Melissa C Fischer $2,705 ($2,705 in general payments such as food, travel and fees) from 14 companies. The largest payer was Medtronic, Inc. with $1,668.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 14 | $1,668 |
| Boston Scientific Corporation BSX | 3 | $296 |
| Biotissue Holdings Inc. | 1 | $174 |
| Sumitomo Pharma America, Inc. 4506.T | 13 | $136 |
| Urogen Pharma, Inc. URGN | 2 | $84.17 |
| Abbvie Inc. ABBV | 3 | $63.73 |
| Olympus America Inc. | 2 | $59.27 |
| Merck Sharp & Dohme LLC MRK | 2 | $50.96 |
| Janssen Biotech, Inc. JNJ | 2 | $39.77 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $36.8 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.